Oncolytic viruses, once considered medical curiosities, are now cutting-edge tools in the fight against some of the most ...
The fears over mRNA-vaccine grant cancellations come after NIH staff members were instructed to compile a list of grants for ...
Asian News International on MSN3d
Bharat Biotech launches India's only integrated cell, gene therapy, and viral production facilityBharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, ...
Vaccine manufacturer Bharat Biotech International Limited (BBIL) is making a foray into the cell and gene therapy (CGT) space ...
Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...
Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...
GlobalData on MSN6d
Anocca gains European authorisation for Phase I/II trial of pancreatic cancer drugAnocca has secured authorisation from regulatory authorities in four European nations for its Phase I/II VIDAR-1 clinical ...
The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.
Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.
India Today on MSN3d
Indian biotech firm pioneers CAR-T cell therapy for cancer treatmentBi-Specific 3rd Generation CAR T therapy is a revolutionary advancement in cellular immunotherapy, primarily used to treat blood cancers such as leukemia, lymphoma, and multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback